van Dijk AE, Olthof MR, Meeuse JC, Seebus E, Heine RJ, van Dam RM
The resulting insights will potentially underpin a payor-facing test to inform reimbursement policy for these widely prescribed drugs based on a patients potential to tolerate and respond to a drug in specific indications
Originally developed to support blood sugar management in people with type 2 diabetes, tirzepatide has become a powerful option for weight-loss management thanks to how it helps regulate appetite and metabolism
10.1128/CMR.00338-20 39 TangW
[First biosimilar etanercept is available]
Were Here to Help Our mission is to provide thoughtful, personalized care, and that doesnt change